FDA Clarifies ICH Guideline on Drug Starting Materials

Drug GMP Report
A A
More than four years after adopting an ICH guideline on manufacturing processes, the FDA has responded to industry questions on starting materials for chemical entity drug substances.

To View This Article:

Login

Subscribe To Drug GMP Report